Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
about
Cell-based therapies for amyotrophic lateral sclerosis/motor neuron diseaseAdult stem cells in neural repair: Current options, limitations and perspectivesRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisHuman glial progenitor engraftment and gene expression is independent of the ALS environmentHuman motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse modelHow stem cells speak with host immune cells in inflammatory brain diseasesNeuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.Fetal stem cell transplantation: Past, present, and future.Amyotrophic lateral sclerosis - cell based therapy and novel therapeutic development.Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the futureCell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.Analysis of graft survival in a trial of stem cell transplant in ALS.Human neural stem cell transplantation in ALS: initial results from a phase I trial.Functional electrical stimulation and spinal cord injury.Regenerative cellular therapies for neurologic diseasesSurgical technique for spinal cord delivery of therapies: demonstration of procedure in gottingen minipigs.Intraspinal stem cell transplantation for amyotrophic lateral sclerosisReverse engineering human neurodegenerative disease using pluripotent stem cell technology.The pharmacology of regenerative medicineTransplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trialsIn Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression.Transplantation of human fetal-derived neural stem cells improves cognitive function following cranial irradiation.Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.An overview of domestic and international clinical trials for delivery of cellular therapies to the spinal cord.Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies.Clinical translation of autologous Schwann cell transplantation for the treatment of spinal cord injury.Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application.Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies.Current status of cell-mediated regenerative therapies for human spinal cord injury.Current perspectives in stem cell therapy for spinal cord repair in humans: a review of work from the past 10 years.Stem cells in neurology--current perspectives.Gene therapy strategies for the treatment of spinal cord injury.Clinically relevant aspects of stem cell technologies: current state of play.Stem cells therapy for ALS.Efficacy of Stem Cell Therapy in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.Plastic changes in the spinal cord in motor neuron diseaseEtiology and treatment of amyotrophic lateral sclerosis.Human neural progenitor cells retain viability, phenotype, proliferation, and lineage differentiation when labeled with a novel iron oxide nanoparticle, Molday ION Rhodamine B.Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model.
P2860
Q24187577-31B5BF06-3FAA-4CFF-B327-AECA5DE7AFB2Q26824821-428AE080-E01B-4F20-BA67-9B4FF336884AQ27338320-3941E91D-9D50-471D-A0A9-16C66BA5156EQ33620690-3DB851AD-4461-4034-9F8E-0579145FC851Q33638440-9FE8DAA6-0296-4150-B081-A6A29A289D44Q33776557-3765AFCC-EFC5-4088-B3F6-426076AB1A6FQ34172960-BA229B19-E5B5-4911-A272-606309BEE517Q34232844-F64BFA07-2EA9-4C37-A9EC-5882DC77964CQ34241565-AD201DBF-0687-49A4-8EDF-01564D1DBE81Q34478634-9544BDDA-687C-42A0-80FD-8A1018DBE2C6Q34544295-75A87B13-5C14-4928-9A47-B6D78DBC69E6Q34692056-0C86B446-C577-4AFB-97B6-10983D0040D8Q35176654-10FA52F6-34A8-4DCF-8331-7951D113B76FQ35900756-5B8E4CBA-6D30-4AB6-B131-059C87692F10Q36522668-D837F2F7-B343-47C7-B7BE-7DD767F07C83Q36594842-19E2075F-2580-4DE8-944D-103CA5CF059FQ36679757-BD440A91-3634-4C91-AC9A-28B142435F44Q36734551-B23C58CD-A239-40B6-8764-D3AE2195609DQ36974665-CB64D1BA-CA8D-4E08-9F01-87B5FED30E84Q37158966-AC07602F-8C3E-4568-A5B2-732729780EF6Q37315468-0D3606D4-376F-41E7-8D3E-8266A7C14CAAQ37491169-74847078-1EF3-4B5E-B5F2-DFA014B73522Q37734609-2CA8F89D-B4F5-4E41-A5CC-5570EB022C77Q38041894-7FD19DEB-5E41-431E-B5FC-E75D576F3347Q38105080-F807F6C1-9E38-4800-B4C0-40CF77566266Q38162020-CA8193B2-D524-43C2-8C47-112D0B3D659CQ38162491-E9780C8F-9E18-4F06-84E5-827B8D9E3513Q38194510-FD86F1E4-23A6-4AD1-9A06-CD95E802FAACQ38210966-B67367EA-50A1-4581-B168-1A1D18762128Q38223156-A1D3EF76-D209-4C11-8D22-87CC43CE6D55Q38223158-18FDB48B-F4ED-4E7B-80F1-DFF8E49ED146Q38226668-BB2A8700-B4AF-45C0-B527-D897FE010810Q38255414-C69B54A9-E9C6-416C-896C-8B073123D86CQ38630465-7986B9BF-6583-4884-A43A-7BF3D9895CC6Q38777893-981847E8-AB42-45FD-B053-B762091E36C9Q41488070-7953BE93-305E-4BDB-8F74-CCC23D7F4051Q42143912-D17BBE69-AB18-4D5E-97A5-3B50FC29B87FQ42259669-6CBE3F22-D0E3-4582-8415-2383DDFC8A6DQ42850315-197F776F-D289-4060-B044-852DFD62B47CQ44315043-8B3EDF0F-96F0-4B19-B942-17CCD467C4F7
P2860
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Intraspinal stem cell transpla ...... e, and lumbar safety outcomes.
@en
Intraspinal stem cell transpla ...... e, and lumbar safety outcomes.
@nl
type
label
Intraspinal stem cell transpla ...... e, and lumbar safety outcomes.
@en
Intraspinal stem cell transpla ...... e, and lumbar safety outcomes.
@nl
prefLabel
Intraspinal stem cell transpla ...... e, and lumbar safety outcomes.
@en
Intraspinal stem cell transpla ...... e, and lumbar safety outcomes.
@nl
P2093
P2860
P1433
P1476
Intraspinal stem cell transpla ...... te, and lumbar safety outcomes
@en
P2093
Bethwel Raore
Crystal Kelly
Jason Taub
Jonathan Glass
Jonathan Riley
Meraida Polak
Nicholas M Boulis
Thais Federici
Vita Kesner
P2860
P304
405-16; discussion 416
P356
10.1227/NEU.0B013E31825CA05F
P407
P577
2012-08-01T00:00:00Z